Epithalon

Epithalon, also spelled epitalon, is the tetrapeptide Ala-Glu-Asp-Gly in the earlier profile. A tetrapeptide has four amino acids. The two acidic side chains make protection strategy, salt form and analytical conditions part of the identity discussion.

The earlier tables include molecular information, suggested limits, sample test results and performance metrics. They are preserved as inherited examples. The supplied page did not include outbound citation links or batch raw data to validate those figures.

The earlier route starts from a glycine-loaded support and uses Fmoc (a temporary chemical protecting group) chemistry to assemble the chain. Temporary side-chain protection on aspartic and glutamic acid reduces unwanted reactions during assembly. Coupling completion and removal of protection need separate checks.

Final cleavage detaches the chain and removes acid-sensitive protection. The resulting mixture still contains by-products and residues. A short sequence can simplify assembly, but it does not remove the need for raw-material qualification or impurity analysis.

Preparative RP-HPLC (reversed-phase high-performance liquid chromatography, which separates mixture components) separates the target from deletion sequences and incomplete deprotection products. A suitable gradient and fraction-testing plan must be developed for the material and equipment. The earlier C18 schedule below is an example, not a validated method.

Desalting and counterion exchange define the chemical form carried forward to freeze-drying. Drying conditions, load uniformity and residual water need their own evidence. Recovery metrics belong to a documented process rather than a general claim that a particular yield is normal.

Identity can be examined through mass, fragmentation and amino acid composition. Purity and peptide content are separate measurements. The earlier panel also lists several screening techniques; their appearance in a table does not establish that each is suitable or validated for this small peptide.

A release panel needs to justify its methods for water, counterions, residual solvents, microbiological quality and related substances. Values in the example certificate are illustrative. They are not findings from a batch inspected by this publication.

The older programme compares storage temperatures, humidity, light and freeze–thaw stress. Stability-indicating methods must detect change in the target and its degradation products. Data at one condition cannot simply be converted into a universal storage period.

Powder and solution stability remain distinct topics. The example shelf-life and process-capability figures in the appendix have no supporting raw data in the supplied site and remain explicitly unverified.

The manufacturing record connects qualified raw materials, in-process checks, purified fractions and the release certificate. Scale-up changes mixing, heat transfer, filtration and drying load. Troubleshooting should connect low crude purity, poor recovery or a failed contamination test to evidence and corrective action.

FDA’s page current as of April 22, 2026 lists epitalon among substances nominated but withdrawn. That is not approval or clearance. Neither a storage example nor an Oath catalogue listing changes that status.

Epithalon tables retain the earlier manufacturing examples. No Epithalon table here validates an operating procedure, release limit or supplier result. The Epithalon examples have no supporting batch raw data; use them to identify document fields, not to infer measured performance.

Epithalon source links are retained below. These references give context for Epithalon manufacturing; they do not validate the numerical examples. Duplicate Epithalon source links retain the citation record.

The earlier Epithalon profile supplied no outbound citation links. These Epithalon schedules are unverified examples and cannot validate a process or establish measured batch performance.